News
A 52-year-old man presented to our orthopedic clinic with an 8-month history of a right distal forearm mass accompanied by ...
Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...
Headache trajectories vary for postmenopausal women who use menopausal hormone therapy, according to a poster presented at ...
In this video from Clinical Trials at the Summit, Lejla Vajzovic, MD, FASRS, of Duke Eye Center, discusses tyrosine kinase inhibitors and gene therapy as different approaches for wet age-related ...
Adults taking a high antihistamine dose vs. placebo before endurance exercise training sessions had less improvement in peak ...
A pharmacogenetics score may help physicians predict which patients with acute myeloid leukemia are more likely to respond to ...
No significant difference in mortality was observed at 96 hours among children with severe acute malnutrition and ...
The American College of Rheumatology is “disappointed” in the reductions to Medicaid funding included in the newly signed One ...
Male adolescents who underwent bariatric surgery had an increase in free testosterone after surgery that was not tied to a ...
Initiating pharmacological treatment in patients aged at least 80 years who have had a fracture appears to be beneficial, researchers reported at ENDO 2025. Gianina Flocco, MD, a resident at Cleveland ...
Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women ...
In patients with acquired hypothalamic obesity, setmelanotide reduced BMI at 52 weeks compared with placebo, according to results of the TRANSCEND trial presented at ENDO 2025. For the phase 3 trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results